Clinical Trial Update: DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary Tuberculosis

View source ↗

Summary

A Karolinska Institutet clinical trial is investigating DoseTB, an individualized, model-informed dosing approach for pulmonary tuberculosis, and is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Snippet

Sponsor: Karolinska Institutet | Conditions: Tuberculosis, Pulmonary | Status: RECRUITING